EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS197-13615 
Organism
Homo sapiens 
Tissue/cell
ZR75-30 
Coordinate
chr21:39615580-39618640 
Target genes
Number: 2             
NameEnsembl ID
TF binding sites/motifs
Number: 17             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr21:39617621-39617639GAAAGGAAAGAAAGAAAG+6.03
EWSR1-FLI1MA0149.1chr21:39617516-39617534GAAAGAAAGAAAGGAGGG+6.09
EWSR1-FLI1MA0149.1chr21:39617543-39617561GAGAGGAAGGAAGGGAAG+6.25
EWSR1-FLI1MA0149.1chr21:39617650-39617668GAAAGGAAGGAAGGAGAA+6.46
EWSR1-FLI1MA0149.1chr21:39617520-39617538GAAAGAAAGGAGGGAAGG+6.98
EWSR1-FLI1MA0149.1chr21:39617528-39617546GGAGGGAAGGAAGGAGAG+7.58
EWSR1-FLI1MA0149.1chr21:39617524-39617542GAAAGGAGGGAAGGAAGG+8.69
GLI2MA0734.2chr21:39617787-39617802AGACCACCCACAAAG+7.02
GLIS3MA0737.1chr21:39617788-39617802GACCACCCACAAAG+6.26
HNF1AMA0046.2chr21:39618019-39618034AATTAATAATTAAAT+6.58
IRF1MA0050.2chr21:39617639-39617660AGAGAGAAAGAGAAAGGAAGG-6.44
ZNF263MA0528.1chr21:39617544-39617565AGAGGAAGGAAGGGAAGGGAA+6.25
ZNF263MA0528.1chr21:39617545-39617566GAGGAAGGAAGGGAAGGGAAA+6.2
ZNF263MA0528.1chr21:39617659-39617680GAAGGAGAAAGAGAATGAAAG+6.36
ZNF263MA0528.1chr21:39617537-39617558GAAGGAGAGAGGAAGGAAGGG+6.45
ZNF263MA0528.1chr21:39617533-39617554GAAGGAAGGAGAGAGGAAGGA+6.94
ZNF263MA0528.1chr21:39617525-39617546AAAGGAGGGAAGGAAGGAGAG+6.99
Number of super-enhancer constituents: 6             
IDCoordinateTissue/cell
SE_09241chr21:39616014-39619090CD14
SE_45623chr21:39615784-39618542Osteoblasts
SE_51700chr21:39615831-39618527Skeletal_Muscle_Myoblast
SE_55658chr21:39611717-39618807u87
SE_63489chr21:39615519-39618707HSMM
SE_67472chr21:39611717-39618807u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr213961574939615790
chr213961608139616344
chr213961679239617335
Number: 2             
IDChromosomeStartEnd
GH21I038246chr213961851639618880
GH21I038244chr213961593039618220
Enhancer Sequence
TGATCTGCCC GCCTCGGCCT TCCAAAGTGC TGGGATTATA GGCGTGAGCC ACCATGCCCA 60
GCCTATATTT CTTTATCACA ACTCTGCAAC TCTGCCATTT TAGCCTGAAA ACAGCCATAA 120
ACAATTTGTG AACAAATGGG CATGGCTGTC TTGAAATGAA ACTTTATTTG CAAAAAACAA 180
ATGACAGGCT GCATTTGACC TGGGAGCTAT AGTTTGCTGG CCCAGCACTA GACGGTTATT 240
GTCATAAAAT AACCATTTTC TAAAAACGAA CTCTTTGTTT CCACTGTGTT TCTGAGTAAG 300
TTACATGAGA TCATTTAAGT TTCATTTCTA TTGTTGGCCA TTTGTTATAT GAATAAAGAT 360
TTGCTAAGTG ACCCTCAAGC TTGGGTCTTT ATTTCATTTT TAGATTATAT AAGGCTTGAC 420
CCACTTAAGA AATGTAACCG TCTTTTTATT TCTCCTATTA ATTTTTTTTT TGTCTTTGTG 480
ACTATCTTGT TTATACAAAC TGAACCTGAG ACAAAGCCGC TAGTGACTGC TTTTTGTGGT 540
TAAACTGGTT TCGAACCCAC CAAAGTCTAG AAGAGGGAAA GAAAGAATTG TACCAGATTT 600
GATGTGTTTT GTGTAACGTA AGCCAGATTG TACCTCCTTC TCTCTCTCCC AGGTCTGTAT 660
ACAACTTAGG ACCAAGAGGT GGACTTTGGT GTCTTAGTTC AAGCTCTAAA AATACCAGGG 720
AAGCAGGGAC CACGACACAT CCCAGGCTTG GTGCAGAAAC CTGACCTGAA TTGGACCTTA 780
AGATCAGAAT ATAGATCTAT TGTCTTTCCT CACCTGGCTG TTACCAAACT AACTTCCGCA 840
TCTCCTGGGA GTGCTTTCTA TTTCATCCAG GCAGTGCCCT TATCTGATCT GGAGTGGGTT 900
TATCTCTGGG AGAGCTATTG AAGTGCCTGA CAGGAGAGGA CACTAAGAGT ACCTCCAGTC 960
TCCAACTGCC TCCTCCGGCA GAACTGAGCA AGTCCTAACC ATGCCAAAAA CATCATTATC 1020
TCTGGTTCCA TCTTAGTCCC TGCACACCCT AGGATTCAAG GACTCAAGTA AGTTGGGGAG 1080
GGGAACATCT TTTCACCCCT GGAAAACCTT GTCTCCTCCC AAGCCCTGGG AGGGGAGAAC 1140
TGCTGCTAAT GAGATGCTGG TAGTTAGTCT TGTAATTTTT ACAGTATTAT CTGCAGAATG 1200
AATGACTACC AGCAGGTACT CTGAATCTCT TTTCTTTCTA ATAAGATGTA ATCAACGAAC 1260
CAGATTGTGG CCTTGGAGCT GACCAAAGGA TCAGCTAAAG GAATTGGACA CATCCTGAGC 1320
TAGTTAACAC ATGGGTATTG TCGGTCTAAG ATGCTCTTTA GGGGCTAGTG ACTCATTCAT 1380
GATGTGCAGG AAATGGCACA GACACCTCCA TGACCACAGA AGGTTTCTAC AGGCGCCGTC 1440
ATCACAGGGT CTACAAACAG AAGGAAGTCA GAGAGAGAGG CTCAGGGGAA GGCAAGGCGG 1500
GGCTGGAGAC CTGGATTCTA CGTCGGAGTT TACCGCATCC TGGTTCTATT CCCAAAGTCC 1560
TCTCTGTGTG GCCATATGCC TGATTCTCAG CCTGGCTTCA TTCCAGTCAT CTCAGGATCT 1620
TACAAACAAC ATTGATGTCC AGGCCCCACC CCAGACCAAT GAAATCAGAA TCTCTTGGAC 1680
ATTAAAAAAA AAAATGAGTG ATTCTTTCTG GGTGATTCTA ATATGTGGTC AGGGTTGAGG 1740
CCACTGCTTT ACTTCATTAC ATCATGACAC TAAAAATACT ACTGGAAAGA AAAAAGGAGG 1800
GCTACCATCT GCCTTCCAAT CTCTTCAGCT GGGAACCTCT TCATAAGACT GTATCTGAAA 1860
CCAGGATACG AGATCCTTAT AAGTAATTCC ATTTATAATA ACAAAGAAAG AAAAGAAAGA 1920
AAGAAAGAGA GAGAGAGAAA GAAAGAAAGG AGGGAAGGAA GGAGAGAGGA AGGAAGGGAA 1980
GGGAAAGAGA GACAGAGAAA GGAAAGAAGA AAGAAAGAAG GAAAGGGAAG AAAGAAAGAA 2040
GGAAAGGAAA GAAAGAAAGA GAGAGAAAGA GAAAGGAAGG AAGGAGAAAG AGAATGAAAG 2100
GTGTTTACAG CTGGAAATCA AACAGAACTT TGCCTGACAC ATGTTCATTT TTGGCCATTT 2160
TTGCCTTTTT TGTGGTGTGA ACCATTAGTT CAGCCCAGTT AACCCTGAGA CCACCCACAA 2220
AGACTGAATT CAGAGGTGGC TGTCCAGTAC AGTGATTCAA GGTGAGGCCT GTGAAGTGAG 2280
ATCAAGATTT GAATTTCTGC TTCTCAGTTC ACCAACTATT TGACCTTGGG CAAGTGACTT 2340
AATTCAAGAC TTAGTTTTAT CATTTATAAA GTAAGAAGAA TAATACCTGT CTTACATACT 2400
CTGATTTGTT GATATGATAG TCAATATGCT ATAAGAATAA ATTAATAATT AAATGACACG 2460
GTAGACATAA GGCATTTAAA TCTAATTCCT GATCCACAGC AAACCTTCAA CAAATAGCAG 2520
CTGTTATCAT CAGAGCTAAA ACGAATCATG TATCTAGGCT AGGGTCTGGT TTCTTTGCTG 2580
TTTTGGATAA TGGCTTAGGA ATAAGAATAA TGCCCACTGA AGAAGTCTTG ATTTTTCTTA 2640
AAGCTCTAAG CTCACTAGAG TTTTTTGCGT GTTGCCAATT TCAATCAGAT CCAGGAGTAT 2700
TGGTTACTGT TGGCCTATAT GATGAAGATT AACTTTTGGA AGAATCTTTC TGTGGAATGC 2760
AGGCCAAAAG AATTCTGAGG CTGCTTTTGA TTTGCTTTGA GTTCGTTGCA GCTAATGTGA 2820
AGGATGCAAA TATTTCTATA TTCCCTACTA TCTGCTTGGG GTCTTCAAGA GATGAGTTAC 2880
AGTGACCTGG AGGTAACATT TTAAAAATGC TAGTTAAGAT TAGTGTTAAA AACACAGACA 2940
AAGTCTGAAT CTCTCCAATG CTTGATTTTA ATTTTTAAAA AAGAGGAACA TATTACAAAG 3000
GAAGCAGAAT TTCAACATAA TCTTTAGATG GTAAATTATG TTTTACATTA GTCTGCATTA 3060